title: [Cognitive disturbances in patients with tics and Tourette's syndrome and their correction with encephabol].
abstract: Ninety-four patients with tick hyperkinesis (57) and Tourette's syndrome (37) were studied. Neuropsychological examination revealed memory, attention and audio-motor disturbances and symptoms of dysgraphia and dyslexia. Cognitive impairment may develop before ticks appearance and aggravate during hyperkinesis exacerbation. In the patients with Tourette's syndrome, cortical dysfunctions were mostly pronounced. These cognitive disturbances correlated with the indices of spectral analysis of bioelectrical brain activity in frontal and temporal areas. In 83 patients, an efficacy of encephabol treatment combined with basic therapy was studied. Encephabol given in dosage 200-300 mg daily to patients aged 5-7 years and 600 mg--to those aged over 7 years during 6 weeks significantly improved memory, attention and praxis function.
authors.forename: V P
authors.initials: VP
authors.lastname: Zykov
authors.forename: O I
authors.initials: OI
authors.lastname: Begasheva
mesh_terms: D000293:Adolescent; D000367:Age Factors; D001921:Brain / Q000503:physiopathology; D002648:Child; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D005062:European Union; D005260:Female; D006801:Humans; D008297:Male; D011746:Pyrithioxin / Q000008:administration & dosage / Q000627:therapeutic use*; D013981:Tic Disorders / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors; D005879:Tourette Syndrome / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D011746:Pyrithioxin